Danjo Wataru, Fujimura Naoyuki, Ujike Yoshihito
Department of Emergency Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Acta Med Okayama. 2008 Apr;62(2):101-7. doi: 10.18926/AMO/30964.
We investigated the effects of pentoxifylline (PTX) on endotoxin-induced diaphragmatic dysfunction in vitro. Seventy-two rats were divided into 3 groups: a group in which endotoxin (20 mg/kg) was injected intraperitoneally (endotoxin-group), a group in which PTX (100 mg/kg) was injected intraperitoneally 30 min before injection of endotoxin (endotoxin-PTX group), and a group in which only saline was given (sham group). Left hemidiaphragms were removed 4 h after injection of endotoxin. We evaluated the diaphragmatic contractility by twitch characteristics and force-frequency curves in vitro. We measured serum TNF-alpha concentrations, diaphragm malondialdehyde (MDA) levels (an index of oxygen-derived free radical-mediated lipid peroxidation), and diaphragm cAMP concentrations. Diaphragmatic force generation capacity was signifi cantly reduced after injection of endotoxin. Serum TNF-alpha concentrations and diaphragmatic MDA levels were significantly elevated after injection of endotoxin. PTX administration significantly improved diaphragmatic contractility and prevented the elevation in TNF-alpha concentrations and MDA levels after injection of endotoxin. There were no significant changes in the diaphragm cAMP concentrations among the 3 groups. These results demonstrated that PTX administration prevented endotoxin-induced diaphragmatic dysfunction without changing diaphragm muscle cAMP concentrations. The protective effects of PTX against endotoxininduced diaphragmatic contractile deterioration might be caused by attenuating TNF-alpha-mediated oxygen-derived free radical production.
我们在体外研究了己酮可可碱(PTX)对内毒素诱导的膈肌功能障碍的影响。72只大鼠被分为3组:一组腹腔注射内毒素(20 mg/kg)(内毒素组),一组在注射内毒素前30分钟腹腔注射PTX(100 mg/kg)(内毒素-PTX组),一组只给予生理盐水(假手术组)。注射内毒素4小时后取出左半膈肌。我们在体外通过抽搐特性和力-频率曲线评估膈肌收缩力。我们测量了血清肿瘤坏死因子-α(TNF-α)浓度、膈肌丙二醛(MDA)水平(氧衍生自由基介导的脂质过氧化指标)和膈肌环磷酸腺苷(cAMP)浓度。注射内毒素后膈肌产生力的能力显著降低。注射内毒素后血清TNF-α浓度和膈肌MDA水平显著升高。给予PTX可显著改善膈肌收缩力,并防止注射内毒素后TNF-α浓度和MDA水平升高。3组之间膈肌cAMP浓度无显著变化。这些结果表明,给予PTX可预防内毒素诱导的膈肌功能障碍,而不改变膈肌肌肉cAMP浓度。PTX对内毒素诱导的膈肌收缩力恶化的保护作用可能是通过减弱TNF-α介导的氧衍生自由基产生来实现的。